Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2025-12-25 @ 7:53 PM
Study NCT ID:
NCT01441635
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2011-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05-17
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-06
First Submit QC Date:
None
Study First Post Date:
2011-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-09
Results First Submit QC Date:
None
Results First Post Date:
2020-07-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-12-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-07-09
Last Update Post Date:
2021-07-13
Last Update Post Date Type:
ACTUAL